Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 25,901	$ 28,362	$ 49,797	$ 55,118
General and administrative	6,948	6,528	13,922	13,093
Total operating expenses	32,849	34,890	63,719	68,211
Loss from operations	(32,849)	(34,890)	(63,719)	(68,211)
Interest income	2,999	2,615	5,917	5,279
Interest expense	0	(4)	(2)	(23)
Other expense, net	(51)	(124)	(113)	(329)
Loss before income tax provision	(29,901)	(32,403)	(57,917)	(63,284)
Income tax provision
Net loss	$ (29,901)	$ (32,403)	$ (57,917)	$ (63,284)
Net loss per share attributable to common stockholders, basic	$ (0.33)	$ (0.75)	$ (0.68)	$ (1.47)
Net loss per share attributable to common stockholders, diluted	$ (0.33)	$ (0.75)	$ (0.68)	$ (1.47)
Weighted-average common shares used in computing net income (loss) per share attributable to common stockholders, basic	90,632,045	42,957,035	84,848,146	42,957,242
Weighted-average common shares used in computing net income (loss) per share attributable to common stockholders, diluted	90,632,045	42,957,035	84,848,146	42,957,242